BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15712656)

  • 21. Primary cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Sjögren syndrome: A case report.
    Yan X; Jin J
    Medicine (Baltimore); 2018 Feb; 97(8):e0004. PubMed ID: 29465536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for therapy of autoimmune liver disease.
    Ishibashi H; Komori A; Shimoda S; Gershwin ME
    Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis.
    Kaplan MM
    Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of autoimmune hepatic diseases].
    Bueverov AO
    Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate for primary biliary cirrhosis: who is to be trusted?
    Selmi C; Podda M
    Dig Dis Sci; 2010 Nov; 55(11):3013-5. PubMed ID: 20945095
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of autoimmune and cholestatic liver disorders.
    Krok KL; Munoz SJ
    Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis].
    Serghini M; Haddad W; Karoui S; Ben Mustapha N; Kallel L; Fekih M; Boubaker J; Filali A
    Tunis Med; 2012 Oct; 90(10):741-3. PubMed ID: 23096517
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid.
    Renou C; Bourlière M; Martini F; Ouzan D; Penaranda G; Larroque O; Harafa A; Igual JP; Calvet B; Sokolowsky S; Benderitter T; Halfon P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):781-2. PubMed ID: 16677173
    [No Abstract]   [Full Text] [Related]  

  • 30. Autoimmune hepatitis-primary biliary cirrhosis concurrent with biliary stricture after liver transplantation.
    Kang YZ; Sun XY; Liu YH; Shen ZY
    World J Gastroenterol; 2015 Feb; 21(7):2236-41. PubMed ID: 25717264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome developed in a patient with vitiligo and Hashimoto thyroiditis.
    Aksoy EK; Yilmaz B; Köklü S
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):121-2. PubMed ID: 23196727
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary biliary cirrhosis.
    Gong Y; Christensen E; Gluud C
    N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
    Zeng Z; Han YK; Zhang XF; Geng H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of primary biliary cirrhosis].
    Szalay F
    Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
    [No Abstract]   [Full Text] [Related]  

  • 35. [Corticosteroid-induced mediastinal lipomatosis in a patient with overlap syndrome (autoimmune hepatitis-primary biliary cirrhosis)].
    Campos-Franco J; Martínez-De Alegría A; Alende-Sixto R; Gonzalez-Quintela A
    Gastroenterol Hepatol; 2011; 34(7):513-4. PubMed ID: 21636175
    [No Abstract]   [Full Text] [Related]  

  • 36. Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: another step forward.
    Kaplan MM; Bonis PA
    Gastroenterol Clin Biol; 2010; 34(4-5):239-41. PubMed ID: 20462715
    [No Abstract]   [Full Text] [Related]  

  • 37. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy.
    Lim AG; Wolfhagen FH; Verma A; van Buuren HR; Jazrawi RP; Levy JH; Northfield TC; Schalm SW
    Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):155-61. PubMed ID: 9058626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease.
    Heurgué A; Vitry F; Diebold MD; Yaziji N; Bernard-Chabert B; Pennaforte JL; Picot R; Louvet H; Frémond L; Geoffroy P; Schmit JL; Cadiot G; Thiéfin G
    Gastroenterol Clin Biol; 2007 Jan; 31(1):17-25. PubMed ID: 17273128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoconversion of Autoimmune Liver Diseases.
    Yik B; Shah N
    Dig Dis Sci; 2020 Jan; 65(1):71-73. PubMed ID: 31451985
    [No Abstract]   [Full Text] [Related]  

  • 40. [Primary biliary cirrhosis and CREST syndrome: a rare classical combination (literature review and case report)].
    Burnevich EZ; Ignatova TM
    Ter Arkh; 2000; 72(2):66-9. PubMed ID: 10717934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.